Key result
Low-dose indapamide (1.25 mg/day) significantly reduced systolic blood pressure from 173 to 144 mm Hg and diastolic blood pressure from 96 to 80 mm Hg (p < 0.01).
Why the study?
Does indapamide 1.25 mg/day reduce blood pressure in Type II diabetic patients with moderate hypertension and normal or moderately impaired renal function?
Population
28 Type II diabetic patients with moderate hypertension and normal renal function or moderate renal…
Design
Cohort, open label
Follow-up
4 months
Authors
Loading...
May support low-dose indapamide for BP control in diabetic hypertension with renal impairment; leaves open randomized confirmation of outcomes.
Does indapamide 1.25 mg/day reduce blood pressure in Type II diabetic patients with moderate hypertension and normal or moderately impaired renal function?
p-value: p=< 0.01
Low-dose indapamide (1.25 mg/day) effectively reduces blood pressure in diabetic patients with moderate hypertension and normal or moderately impaired renal function.
Madkour et al. (2002) studied Type II Diabetes Mellitus with moderate hypertension (n=28). Indapamide was evaluated on Systolic and diastolic blood pressure (p=< 0.01). Low-dose indapamide (1.25 mg/day) significantly reduced systolic blood pressure from 173 to 144 mm Hg and diastolic blood pressure from 96 to 80 mm Hg (p < 0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: